Anaerobic Coverage: Does Double Equal Trouble?

Anaerobic Coverage: Does Double Equal Trouble?

Advances in environmental sanitation, immunizations, antimicrobial therapy, and medical research have greatly reduced the impact of infectious diseases on our communities. Nonetheless infections and the cost of treating them remain a burden to the health care system.

In primary care practice, we may spend more time making referrals for suspected ID than actually treating infected patients. Here, as a brush up, is the first in our series of 10 practical ID pearls.

1. Do beta-lactam/beta-lactamase inhibitors provide adequate anaerobic coverage or is additional coverage required?

Please leave your comment below, then click here for the answer and discussion



Loading comments...
Please Wait 20 seconds or click here to close